Gladstone NOW: The Campaign Join Us on the Journey✕
Bruce Conklin, MD, and his team at Gladstone Institutes are tackling Charcot-Marie-Tooth (CMT) disease, the most common inherited neurological disorders—for which there is currently no cure.
Using cells collected from patients with CMT, the scientists are exploring ways to use gene editing as a therapeutic tool to treat the disease.
In this video, Bruce Conklin and Bria Macklin describe their work and explain how it could help patients like Jeremy, an energetic 5-year-old who donated his cells to Gladstone for this research.
Content note: The narration in the first 6 seconds of this video was enhanced using an AI-generated voice.
Featured Experts
Gladstone NOW: The Campaign
Join Us On The Journey
Ask a Scientist: When Will Immunotherapy Work on Common Cancers?
Article
June 11, 2025
Ask a Scientist: When Will Immunotherapy Work on Common Cancers?
For Cancer Immunotherapy Month, Karin Pelka answers questions about how immunotherapy can treat patients with solid tumors and the challenges that scientists are working to overcome.
Gladstone Experts Cancer Genomic Immunology Data Science and Biotechnology Pelka LabCulture Is Our Superpower | The Gladstone Difference
Video
May 27, 2025
Culture Is Our Superpower | The Gladstone Difference
Discover how Gladstone fosters an environment in which people are having fun, working hard, and driven to save human lives.
Gladstone Experts Graduate Students and Postdocs Institutional News5 Ways Gladstone Is Harnessing DNA to Overcome Disease
Article
April 24, 2025
5 Ways Gladstone Is Harnessing DNA to Overcome Disease
For National DNA Day, discover how Gladstone scientists are utilizing the power of DNA to deepen our understanding of disease.
Gladstone Experts Genomic Immunology Data Science and Biotechnology Marson Lab Pollard Lab Ramani Lab Shipman Lab Tcheandjieu Lab Big Data CRISPR/Gene Editing